Xylem (NYSE:XYL – Get Free Report) had its price objective dropped by Stifel Nicolaus from $150.00 to $140.00 in a research note issued on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the industrial products company’s stock. Stifel Nicolaus’ target price points to a potential upside of 28.10% from the company’s current price.
Other equities analysts also recently issued reports about the company. Citigroup decreased their target price on Xylem from $152.00 to $134.00 and set a “buy” rating for the company in a research note on Monday. Robert W. Baird increased their target price on shares of Xylem from $139.00 to $148.00 and gave the company an “outperform” rating in a research note on Wednesday, February 5th. Three equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $147.33.
Read Our Latest Research Report on Xylem
Xylem Trading Up 0.1 %
Xylem (NYSE:XYL – Get Free Report) last issued its quarterly earnings data on Tuesday, February 4th. The industrial products company reported $1.18 EPS for the quarter, topping analysts’ consensus estimates of $1.12 by $0.06. Xylem had a net margin of 10.40% and a return on equity of 9.96%. The firm had revenue of $2.30 billion for the quarter, compared to analyst estimates of $2.18 billion. During the same quarter in the previous year, the business posted $0.99 EPS. The firm’s revenue was up 8.6% compared to the same quarter last year. As a group, analysts predict that Xylem will post 4.65 EPS for the current year.
Hedge Funds Weigh In On Xylem
A number of hedge funds have recently made changes to their positions in XYL. Dempze Nancy E lifted its holdings in shares of Xylem by 0.3% during the fourth quarter. Dempze Nancy E now owns 25,761 shares of the industrial products company’s stock valued at $2,989,000 after acquiring an additional 88 shares during the period. Townsquare Capital LLC raised its position in shares of Xylem by 0.8% during the 4th quarter. Townsquare Capital LLC now owns 11,074 shares of the industrial products company’s stock valued at $1,285,000 after acquiring an additional 88 shares during the last quarter. Keel Point LLC lifted its holdings in Xylem by 4.1% during the fourth quarter. Keel Point LLC now owns 2,371 shares of the industrial products company’s stock worth $275,000 after acquiring an additional 93 shares in the last quarter. Clear Creek Financial Management LLC increased its position in shares of Xylem by 4.3% during the fourth quarter. Clear Creek Financial Management LLC now owns 2,315 shares of the industrial products company’s stock worth $269,000 after acquiring an additional 96 shares in the last quarter. Finally, Bleakley Financial Group LLC raised its position in Xylem by 2.3% in the 4th quarter. Bleakley Financial Group LLC now owns 4,359 shares of the industrial products company’s stock valued at $506,000 after buying an additional 96 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.
About Xylem
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Featured Articles
- Five stocks we like better than Xylem
- Upcoming IPO Stock Lockup Period, Explained
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
- Manufacturing Stocks Investing
- Gold Rally Continues: These 3 Mining Stocks Are Likely to Benefit
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- XPO Buying $50 Million of Its Own Stock: Here’s Why
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.